MedTrace Logo

Effects of Ultrasound Therapy in Iliotibial Band Syndrome

NCT07534605 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2026-04-16

No results posted yet for this study

Summary

The aim of this study is to investigate the effect of ultrasound (US) therapy, administered in different modes, on pain, functionality, quality of life and iliotibial band (ITB) thickness in patients with iliotibial band syndrome (ITBS). The primary question of the study is: Is US therapy effective in reducing pain and improving functionality in ITBS? The secondary question is: Is US therapy effective in ITBS in terms of quality of life and ITB thickness? 75 participants were assigned to the exercise, exercise plus continuous US and exercise plus intermittent US groups and received 15 treatment sessions. Participants were assessed before treatment, at the end of treatment (after 15 sessions) and at 3 months post-treatment.

Conditions

  • Iliotibial Band Syndrome

Interventions

BEHAVIORAL

Exercise

Hip and knee strengthening, core muscle strengthening, and ITB stretching exercises were given in 15 sessions.

DEVICE

Continious Ultrasound

2 W/cm² intensity, 1.5 MHz frequency, 7 minutes, 15 continuous ultrasound sessions.

DEVICE

Intermittant ultrasound

2 W/cm² intensity, 1.5 MHz frequency, 7 minutes per session, 15 pulsed ultrasound treatments.

Sponsors & Collaborators

  • Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-15
Primary Completion
2025-11-19
Completion
2025-11-19

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07534605 on ClinicalTrials.gov